A low-cost
biochip based blood test that can identify people at a higher risk of Alzheimer’s
disease in just three hours has been developed. A study showed that the test,
which allows multiple tests to be run on one blood sample, was accurate as
existing molecular tests that analyse DNA. This is the first time that
researchers have used this technology to test for an increased risk of
Alzheimer’s. This can empower patients to understand risks, consider
medication. This test detects the presence of protein in the blood produced by
a specific variation of apolipoprotein gene (ApoE4), which is associated with
increased risk of developing Alzheimer’s disease. The apolipoprotein gene is
inherited from each parent and when a patient inherits the ApoE4 variant from
one parent they have a three times greater risk of developing Alzheimer’s,
whereas a patient who inherits ApoE4 from both parents is 8-to-12 times more
likely to develop the disease.
No comments:
Post a Comment